10x Genomics, Inc. stock is up 22.79% since 30 days ago. The next earnings date is Feb 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 4 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
12 Oct 19:57 | 17 Nov, 2023 | 40.00 | 37 | ||
01 Nov 17:29 | 17 Nov, 2023 | 40.00 | 222 | ||
01 Nov 17:29 | 17 Nov, 2023 | 40.00 | 222 | ||
01 Nov 17:37 | 17 Nov, 2023 | 40.00 | 222 | ||
03 Nov 13:55 | 17 Nov, 2023 | 30.00 | 7 | ||
03 Nov 14:57 | 17 Nov, 2023 | 30.00 | 7 | ||
17 Nov 19:04 | 15 Dec, 2023 | 35.00 | 32 | ||
17 Nov 19:14 | 15 Dec, 2023 | 35.00 | 32 | ||
17 Nov 19:32 | 15 Dec, 2023 | 35.00 | 32 | ||
20 Nov 15:37 | 15 Dec, 2023 | 40.00 | 411 |
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression.